Repurposed cancer drug shows promise for Parkinson’s

News

Author: Simge Eva DoganPublished: 5 December 2018

Prep: Cook: Serves:

Researchers at the Oxford Parkinson’s Disease Centre, UK, have repurposed an experimental cancer drug – called tasquinimod – as a potential treatment for Parkinson’s.

The study – funded by Parkinson’s UK and published in science journal ‘Cell Stem Cell’ – has been tested on a total of 10 patients so far.

As part of the research, the study grew brain cells from donated skin cell samples of people living with a rare genetic form of Parkinson’s – this process was then repeated on people with a common non-genetic form of the condition. Researchers found that tasquinimod can block HDAC4, a protein that causes Parkinson’s genes to become inactive.

Professor Richard Wade-Martins, co-lead author of the study, said: “We think that switching off these genes in brain cells may play a vital role in the cell damage and death that occurs in Parkinson’s.”

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit the EPDA website.

World’s largest Parkinson’s study seeks 10,000 participants

Last Month

Next Month

Go Back

Share this story

Comments

Advances

New NHS toolkit to offer people with Parkinson’s “highest quality care”

The initiative could save £10m to reinvest in care services

Neurologists should be ‘guides not gods’ – Part 2

Top expert Bastiaan Bloem argues the case for a more holistic approach

Who said what: QoTW 11.06.15

Our favourite quotes of the week from around the web

New tool could support “faster diagnosis” of Parkinson’s disease psychosis

A new screening tool has been developed to support the early diagnosis of Parkinson’s disease psychosis – a symptom of the condition that is often misdiagnosed. Created by Canadian senior care software company, PointClickCare and membership organisation, the American Society of Consultant Pharmacists (ASCP), the platform asks questions on topics like hallucinations and delusions. Healthcare workers can then review the responses and decide to collect more information and create a care plan. Data collected through the tool will also be used to help scientific research in healthcare organisations. Bill Stuart, clinical product strategist at PointClickCare said: “Not only will the screener tool better enable faster diagnosis, it will provide the senior care industry with a consistent way of approaching Parkinson’s psychosis.” Chad Worz, chief executive of ASCP, added: “We are excited to have another tool for care teams to facilitate a more standardised care process for Parkinson’s disease and we…

Has Covid-19 impacted access to Parkinson’s medication?

New research has found that the coronavirus pandemic has affected access to medication for people living with Parkinson’s disease. The sub-study used information from a survey conducted by the International Parkinson and Movement Disorder Society. The results from 346 participants showed that 22.8% of high-income and 88.9% of low-income countries’ respondents agreed that the coronavirus crisis had impacted people’s access to Parkinson’s medication. Some respondents reported increased disability, increased hospitalisation and increased mortality as factors. The majority of those who completed the survey were doctors. The researchers concluded: “Our results offer preliminary data that the Covid-19 pandemic has affected Parkinson’s disease patients’ access to regular medication. “Covid-19 has diverted resources away from chronic conditions towards the fight against Covid-19 in many countries. Resource-poor countries seem to be disproportionately affected compared to their affluent counterparts.”

Brazilian dance could improve mobility in people with Parkinson’s, study finds

Researchers at the Federal University of Rio Grande do Sul in Brazil compared participants in a 12-week programme, inspired by samba and forró dances, with those in a walking exercise programme to measure improvement in their functional mobility and gait. The 18 participants had an average age of 68.6 and had all been diagnosed with Parkinson’s over a year ago. The results, published in journal BMC Neurology, found that both groups showed significant improvements in mobility and balance tests. Participants in the dance group showed increases in stride frequency at a self-chosen test speed and a reduced swing time (the amount of time the foot is off the floor) at a fast speed. The results indicated that dance was as “effective as walking in improving functional mobility”. The researchers wrote: “It is essential to find different activities that can offer benefits to individuals… so that they can engage in the…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

Repurposed cancer drug shows promise for Parkinson’s

News

Author: Simge Eva DoganPublished: 5 December 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Advances

New NHS toolkit to offer people with Parkinson’s “highest quality care”

Special reports

Neurologists should be ‘guides not gods’ – Part 2

Perspectives

Who said what: QoTW 11.06.15

New tool could support “faster diagnosis” of Parkinson’s disease psychosis

Has Covid-19 impacted access to Parkinson’s medication?

Brazilian dance could improve mobility in people with Parkinson’s, study finds

{title}

Subscribe

Repurposed cancer drug shows promise for Parkinson’s

News

Author: Simge Eva DoganPublished: 5 December 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Advances

New NHS toolkit to offer people with Parkinson’s “highest quality care”

Special reports

Neurologists should be ‘guides not gods’ – Part 2

Perspectives

Who said what: QoTW 11.06.15

New tool could support “faster diagnosis” of Parkinson’s disease psychosis

Has Covid-19 impacted access to Parkinson’s medication?

Brazilian dance could improve mobility in people with Parkinson’s, study finds

{title}

Subscribe

Sign in